Inhalation route inducing subacute cutaneous lupus erythematosus with tiotropium [8]

Archives of Dermatology

Volumn 141, Issue 7, 2005, Pages 911-912

  Pham, Hoang Chinh ^a   Saurat, Jean Hilaire ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TIOTROPIUM BROMIDE;

ADULT; ANAMNESIS; ANTICHOLINERGIC EFFECT; BLOOD ANALYSIS; CASE REPORT; CELL DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG INDUCED DISEASE; HISTOPATHOLOGY; HUMAN; HYPERKERATOSIS; INHALATION; LABORATORY TEST; LETTER; LEUKOPENIA; LYMPHOCYTIC INFILTRATION; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN ATROPHY; SKIN DEFECT; SKIN LUPUS ERYTHEMATOSUS;

ADMINISTRATION, INHALATION; BIOPSY, NEEDLE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LUPUS ERYTHEMATOSUS, CUTANEOUS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REMISSION, SPONTANEOUS; RISK ASSESSMENT; SCOPOLAMINE DERIVATIVES; SEVERITY OF ILLNESS INDEX;

EID: 23044500704     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.141.7.911     Document Type: Letter

References (5)

1. Srivastava M, Rencic A, Diglio G, et al. Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus. Arch Dermatol. 2003;139:45-49.
2. Pramatarov KD. Drug-induced lupus erythematosus. Clin Dermatol. 1998;16:367-377.
3. Bonsmann G, Schiller M, Luger TA, et al. Terbinafine-induced subacute cutaneous lupus erythematosus. J Am Acad Dermatol. 2001;44:925-931.
4. Begaud B, Evreux JC, Jouglard J, et al. Imputation of the unexpected or toxic effects of drugs: actualization of the method used in France. Therapie. 1985;40:111-118.
5. Budavari S, O'Neil MJ, Smith A, Heckelman PE, eds. The Merck Index. 11th ed. Rahway, NJ: Merck & Co Inc; 1989:870, 1614.